Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes
The largest of these (still fairly small, n=159) was a randomized and controlled clinical trial published in the New England Journal of Medicine , and found that a dose of 100 mcg twice per day improved quality of life, reduced eye involvement, and slowed disease progression among participants with mild Graves' orbitopathy (compared to pentoxifylline or placebo)
Takashima S, Tanaka F, Kawaguchi Y et al (2020) Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice
Mesenchymal stem cells in aplastic anemia and myelodysplastic syndromes: The 'Seed and Soil' Crosstalk
Perspectives on chronic kidney disease with type 2 diabetes and risk management: practical viewpoints and a paradigm shift using a pillar approach
ii) Reversal of hyperinsulinemia: This represents one of the central mechanisms